ClinicalTrials.gov
public full text
Public Domain
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
The purpose of this study is to see if PET/CT scans that use a radioactive substance called \[18F\] fluorothymidine (FLT), can detect and monitor changes in the tumor. Radioactive substances are used with PET/CT scans to "see" cancer cells, and are also called radiotracers. FLT is a new radiotracer that has been given to people in prior studies. FLT PET/CT is an experimental scan unlike FDG (fluorodeoxyglucose) PET scan which is a standard clinical scan and is commonly used. The investigators would like to know if there is any evidence of early treatment response by obtaining FLTPET/ CT scans before and after treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- [18F]FES PET/.CT in Uterine Cancer#832044
- FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents#902379
- Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET#909882
- [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib#889172
- FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia#812397
Record · ID 1375750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive